WebbFör 1 dag sedan · ![Figure][1] Wolfgang A. Weber The term theranostics has clearly become a buzzword. To a large extent, this is due to the success of prostate-specific membrane antigen (PSMA)–targeted radioligands. These ligands can be labeled with positron- or γ-emitting isotopes for imaging or with Webb2 aug. 2024 · PSMA Theranostics: Science and Practice Authors Kgomotso Mokoala 1 , Ismaheel Lawal 1 2 , Thabo Lengana 3 , Mankgopo Kgatle 2 , Frederik L Giesel 4 , Mariza …
Michael Hofman on LinkedIn: #movember #psma #research #theranostics
Webb23 mars 2024 · Pluvicto TM (lutetium Lu 177 vipivotide tetraxetan) is indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have already been treated with other anticancer treatments (androgen receptor pathway inhibition (ARPI) and … WebbProstate-specific membrane antigen (PSMA) is a credentialed imaging and therapy (theranostic) target for the detection and treatment of prostate cancer. PSMA-targeted … ionic steam iron
PSMA Theranostics: Current Landscape and Future Outlook - MDPI
Webb1 aug. 2024 · Theranostic ligands are used to image disease or selectively deliver cytotoxic radioactivity to cells expressing PSMA according to the radioisotope conjugated to the … Webb26 maj 2024 · Prostate-specific membrane antigen (PSMA) has been the subject of extensive investigation in the past two decades as a promising molecular target for … WebbGCPII also known as Prostate Specific Membrane Antigen (PSMA), is overexpressed in prostate cancer (PCa) cells and provide a biomarker for tumor targeting PSMA receptor. The development of lysine-urea-glutamate pharmacophore based inhibitors targeting PSMA for theranostics applications led to PSMA11 and PSMA617. ontario works arnprior